Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01097915
Other study ID # UNICADBSITB-1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2009
Est. completion date June 2016

Study information

Verified date December 2018
Source University of Cagliari
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators evaluate the possible association of PROP taste with gustin gene polymorphism rs2274333 (A/G), salivary zinc ion concentration and BMI. In addition, it has also been evaluated PROP taste sensitivity by recording monophasic potentials from the tongue.


Description:

The investigators evaluate the possible association of PROP taste with gustin gene polymorphism rs2274333 (A/G), salivary zinc ion concentration and BMI.

Furthermore, we apply direct measures of the gustatory system activation following stimulation with PROP, obtained by electrophysiological recordings from the tongue of subjects classified for taster status, genotyped for the specific receptor gene (TAS2R38), and in which papilla density was determined.


Recruitment information / eligibility

Status Completed
Enrollment 170
Est. completion date June 2016
Est. primary completion date December 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 30 Years
Eligibility Inclusion Criteria:

- no variation of body weight > 5 kg over the last 3 mo BMI within 20-25 Age between 20-30

Exclusion Criteria:

- gustatory impairment following a prescribed diet or using medications that might interfere with taste perception food allergies smokers

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Italy Sezione di Farmacologia Clinica del Dipartimento di Neuroscienze, San Giovanni di Dio Azienda Ospedaliero Universitaria di Cagliari Cagliari Ca

Sponsors (1)

Lead Sponsor Collaborator
University of Cagliari

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Association Between Gustin Gene Polymorphism and PROP Sensitivity We examine associations between PROP status and the polymorphism rs2274333 (A/G) of the gene that codify for the salivary protein, gustin/CA6, Which has been suggested as a trophic factor that promotes growth and development of taste buds by acting on taste bud stem cells.
The intensity of taste perception evoked by PROP and NaCl solutions was estimated to evaluate PROP taster status and molecular analysis of the gustin gene polymorphism was performed in individuals classified by PROP status using PCR techniques.
7 months
Secondary Association Between PROP Sensitivity and Saliva Zinc Ion Concentration Since the enzymatic function of gustin (CA6) depends upon the presence of Zn at its active site we measured the salivary zinc ion concentration in subjects classified as super-taster, medium taster and non-taster.The salivary Zn2+ concentration was measured with a QuantiChromTM zinc Assay kit (Gentaur, Brussels, Belgium) where the color intensity is directly proportional to the Zn2+ concentration in the sample. 7 months
Secondary Association Between PROP Sensitivity and BMI Since individual ability to taste PROP may be correlated with BMI, we determined BMI (kg/m^2) in subjects classified as super-taster, medium taster and non-taster.Weight (kg) and height (m) were recorded for each subject. 7 months
Secondary Electrophysiological Recordings From the Tongue for the Objective Evaluation of Individual Variations of 6-n-propylthiouracil (PROP) Sensitivity electrophysiological recordings from the tongue of 43 subjects classified for their taste sensitivity to 6-n- propyltiouracil (PROP) and genotyped for the specific receptor gene, TAS2R38. Density of fungiform papillae was also determined in each subject. The biopotentials were recorded by means of differential electrophysiological derivations between two silver electrodes, one in contact with the ventral surface of the tongue and one in perfect adhesion with the dorsal surface. 1 year
Secondary Association Between PROP Sensitivity and Fungiform Papilla Density 43 subjects were classified for their taste sensitivity to 6-n- propyltiouracil (PROP) and density of fungiform papillae was determined in each subject. 6 months
Secondary Taste Perception of Sweet, Sour, Salty, Bitter and Umami and Changes Due to L-Arginine Supplementation, as a Functin of Genetic Ability to Taste PROP. Taste perception was assessed by testing the ability to recognize, and the responsiveness to, representative solutions of the five taste qualities, also when supplemented with L-Arg, in subjects classified as PROP-tasters. 8 months
See also
  Status Clinical Trial Phase
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Recruiting NCT03210441 - Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer N/A
Completed NCT00036881 - Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer Phase 3
Not yet recruiting NCT06311877 - Effects of Flavor Modification for Management of Radiation Induced Dysgeusia N/A
Recruiting NCT04791436 - Oral and Olfactory Complications of Recovered COVID-19 Patients
Recruiting NCT04384042 - Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study
Completed NCT04390165 - Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study
Completed NCT05868850 - Application of Auricular Point Sticking in Patients With Taste Alteration N/A
Recruiting NCT05486260 - Effect of Dried Miracle Berry on the Olfactory-gustative Perception in Malnourished Cancer Patients N/A
Withdrawn NCT05760079 - Lactoferrin for COVID-19-Induced Taste or Smell Abnormality N/A
Completed NCT04473157 - COVID-19 in Patients With Anosmia in Egypt
Recruiting NCT02304913 - Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy N/A
Completed NCT01596634 - Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy N/A
Completed NCT04543175 - Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.
Completed NCT01540045 - Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Completed NCT04629560 - Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy Early Phase 1
Recruiting NCT02475928 - Zinc Supplementation in Cirrhotic Patients N/A